Ipratropium
Active pharmaceutical substance formulated in Jan Aushadhi generic products for Respiratory & Allergy treatment.
🧴 Clinical Application
Inhale 2 puffs four times daily through the MDI device (maximum 8 to 12 puffs daily). In acute exacerbations, take 2 puffs repeated every 20-30 minutes for up to 1 hour under clinical supervision. Use a spacer device for maximum lung delivery.
⚠️ Side Effects
Common: Dry mouth, fine skeletal muscle tremor (hands), palpitations, tachycardia, headache, nervousness, throat irritation. Rare/Severe: Paradoxical bronchospasm, acute urinary retention, narrow-angle glaucoma attack (if sprayed in eyes), and hypokalemia.
🛡️ Safety Warnings
Avoid spraying into eyes (can precipitate acute angle-closure glaucoma). Use with caution in patients with prostatic hypertrophy, bladder neck obstruction, or ischemic heart disease. Not for long-term controller therapy in asthma (must use inhaled corticosteroids).
Jan Aushadhi Products containing Ipratropium
Found 4 generic formulation(s) containing this active ingredient.
Levosalbutamol 1.25mg + Ipratropium 500mcg Respules
Salbutamol (100mcg) and Ipratropium Bromide (20mcg Inhaler) combines a short-acting beta-2 agonist (SABA) with a short-acting muscarinic antagonist (SAMA) on the WHO Model List of Essential Medicines. Salbutamol relaxes bronchial smooth muscle via cyclic AMP elevation; ipratropium blocks vagal acetylcholine-mediated bronchoconstriction at muscarinic M3 receptors. This dual-pathway approach produces greater, longer-lasting bronchodilation than either agent alone without added sympathomimetic side effects. Indicated for management of bronchospasm in Chronic Obstructive Pulmonary Disease (COPD) and acute severe asthma exacerbations.
Salbutamol 100mcg + Ipratropium 20mcg Inhaler
Salbutamol (100mcg) and Ipratropium Bromide (20mcg Inhaler) combines a short-acting beta-2 agonist (SABA) with a short-acting muscarinic antagonist (SAMA) on the WHO Model List of Essential Medicines. Salbutamol relaxes bronchial smooth muscle via cyclic AMP elevation; ipratropium blocks vagal acetylcholine-mediated bronchoconstriction at muscarinic M3 receptors. This dual-pathway approach produces greater, longer-lasting bronchodilation than either agent alone without added sympathomimetic side effects. Indicated for management of bronchospasm in Chronic Obstructive Pulmonary Disease (COPD) and acute severe asthma exacerbations.
Levosalbutamol 100mcg + Ipratropium 40mcg Rotacap
Salbutamol (100mcg) and Ipratropium Bromide (20mcg Inhaler) combines a short-acting beta-2 agonist (SABA) with a short-acting muscarinic antagonist (SAMA) on the WHO Model List of Essential Medicines. Salbutamol relaxes bronchial smooth muscle via cyclic AMP elevation; ipratropium blocks vagal acetylcholine-mediated bronchoconstriction at muscarinic M3 receptors. This dual-pathway approach produces greater, longer-lasting bronchodilation than either agent alone without added sympathomimetic side effects. Indicated for management of bronchospasm in Chronic Obstructive Pulmonary Disease (COPD) and acute severe asthma exacerbations.
Ipratropium Bromide Inhaler 20mcg
Ipratropium Bromide Inhaler (20mcg) and Respirator Solution (250mcg per ml) is an inhaled synthetic quaternary ammonium anticholinergic bronchodilator on the WHO Model List of Essential Medicines. It competitively antagonizes muscarinic M1, M2, and M3 receptors on bronchial smooth muscle, blocking acetylcholine released from parasympathetic vagal efferents. Because of its quaternary structure, it does not cross mucosal membranes or the blood-brain barrier, exerting localized bronchodilation with minimal systemic anticholinergic adverse effects. Indicated for maintenance bronchodilation and acute relief of bronchospasm in Chronic Obstructive Pulmonary Disease (COPD) and adjunctive management of severe acute asthma.
Brand Equivalents & Price Comparison
Compare Jan Aushadhi generic prices against popular commercial brands for Ipratropium.
| Generic Formulation | Pack Size | Jan Aushadhi Price | Commercial Brand Equivalents | Avg. Commercial Price | Savings |
|---|---|---|---|---|---|
| Levosalbutamol 1.25mg + Ipratropium 500mcg Respules | 3 ml | ₹9.28 | DUOLIN, COMBIMIST, IPRAZEST | ₹125.29 | 93% Save |
| Salbutamol 100mcg + Ipratropium 20mcg Inhaler | 200 MDI | ₹103.13 | ASTHALIN | ₹217.70 | 53% Save |
| Levosalbutamol 100mcg + Ipratropium 40mcg Rotacap | 60 s in container | ₹70.31 | ASTHALIN | ₹65.31 | N/A |
| Ipratropium Bromide Inhaler 20mcg | 200 MDI | Under Process | N/A | N/A | N/A |
Frequently Asked Questions (FAQ)
Get answers to common queries about Ipratropium generics.